Biocon Biologics

Healthcare

08 November, 2023

Eris Lifesciences acquires two businesses from Biocon arm

Eris Lifesciences Ltd, a Mumbai-listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, has agreed to purchase ......

Healthcare

14 August, 2023

Biocon may list biosimilars business by 2025 first half: CEO

Indian biopharmaceutical company Biocon Ltd is planning to list its biosimilars business, a significant contributor to the company's total revenue, ......

Healthcare

05 December, 2022

Biocon Biologics appoints new MD, CEO

Biocon Biologics on Monday said it has appointed Shreehas Tambe as managing director and chief executive officer of the company. ......

Premium

Healthcare

11 July, 2022

Analysis: M&A deal value in healthcare and pharma hits record high in Jan-June

Merger and acquisitions (M&As) deal value in the healthcare and pharmaceutical space hit a record high in Jan-June, crossing the ......

Healthcare

21 June, 2022

Kiran Mazumdar-Shaw co-founded biotech startup raises Series A funding

Immuneel Therapeutics Pvt Ltd, co-founded by Biocon founder Kiran Mazumdar-Shaw, has raised around $15 million (Rs 116 crore) in a ......

Healthcare

17 September, 2021

PE-backed Biocon Biologics to offer 15% stake to Serum Institute unit

Biocon Biologics, a unit of drugmaker Biocon Ltd, said late on Thursday it would offer a stake of about 15% ......

Premium

Finance

04 February, 2021

Jan Deals Wrap: Adani, Udaan, OmniActive rock the charts

The first month of the new year, which continues to be affected by coronavirus just like 2020, saw a string ......

General

06 October, 2020

Grapevine: New financial reporting norms likely; Goldman Sachs to buy stake in Biocon unit

The ministry of corporate affairs may ask large unlisted firms to file financial statements more frequently with the Registrar of ......

General

27 January, 2020

Grapevine: Tiger Global closes mega fund, likely to lead Dream11 funding

New York-based Tiger Global Management has closed a $3.75 billion (about Rs 26,800 crore at current exchange rate) global private ......

Healthcare

06 January, 2020

True North to invest $75 mn in Biocon's biosimilar unit

Indian biotechnology firm Biocon Ltd on Monday said that private equity firm True North will invest Rs 536.25 crore ($74.84 ......